| miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype DD Chin, C Poon, J Wang, J Joo, V Ong, Z Jiang, K Cheng, A Plotkin, ... Biomaterials 273, 120810, 2021 | 72 | 2021 |
| Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery J Wang, C Poon, D Chin, S Milkowski, V Lu, KR Hallows, EJ Chung Nano Research 11, 5584-5595, 2018 | 66 | 2018 |
| Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease J Wang, D Chin, C Poon, V Mancino, J Pham, H Li, PY Ho, KR Hallows, ... Journal of controlled release 329, 1198-1209, 2021 | 63 | 2021 |
| A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma BS Wong, SR Shah, CL Yankaskas, VK Bajpai, PH Wu, D Chin, ... Nature biomedical engineering 5 (1), 26-40, 2021 | 46 | 2021 |
| Collagenase‐cleavable peptide Amphiphile micelles as a novel Theranostic strategy in atherosclerosis DD Chin, C Poon, N Trac, J Wang, J Cook, J Joo, Z Jiang, NS Sta Maria, ... Advanced therapeutics 3 (3), 1900196, 2020 | 26 | 2020 |
| Exosomes in atherosclerosis, a double-edged sword: their role in disease pathogenesis and their potential as novel therapeutics N Patel, DD Chin, EJ Chung The AAPS Journal 23, 1-15, 2021 | 22 | 2021 |
| Hydroxyapatite-binding micelles for the detection of vascular calcification in atherosclerosis DD Chin, J Wang, MM de Fontenay, A Plotkin, GA Magee, EJ Chung Journal of materials chemistry B 7 (41), 6449-6457, 2019 | 22 | 2019 |
| Therapeutic response of miR-145 micelles on patient-derived vascular smooth muscle cells N Patel, DD Chin, GA Magee, EJ Chung Frontiers in Digital Health 4, 836579, 2022 | 8 | 2022 |
| Calcium-binding nanoparticles for vascular disease DD Chin, S Chowdhuri, EJ Chung Regenerative Engineering and Translational Medicine 5, 74-85, 2019 | 8 | 2019 |
| Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis DD Chin, N Patel, W Lee, S Kanaya, J Cook, EJ Chung Bioactive Materials 27, 327-336, 2023 | 7 | 2023 |
| Oral delivery of kidney targeting nanotherapeutics for polycystic kidney disease Y Huang, J Wang, D Chin, V Mancino, J Pham, H Li, K Jiang, A Ram, ... bioRxiv, 2022.10. 18.512444, 2022 | 2 | 2022 |
| Nanoparticle-mediated microRNA-145 delivery for vascular smooth muscle cell phenotype modulation and atherosclerosis treatment DD Chin, C Poon, J Wang, J Joo, V Ong, Z Jiang, K Cheng, A Plotkin, ... bioRxiv, 2020.09. 09.290361, 2020 | 2 | 2020 |
| Oral delivery of nanomedicine for genetic kidney disease Y Huang, J Wang, V Mancino, J Pham, C O’Grady, H Li, K Jiang, D Chin, ... PNAS Nexus, pgae187, 2024 | | 2024 |
| Mir-145 micelles for mitigating atherosclerosis EJPC YOO, CYH POON, DD CHIN US Patent App. 17/940,460, 2023 | | 2023 |
